SkinCeuticals Silymarin CF | Vitamin C Serum | 30ml

£169.00

Looking for the best deal on this product?

This item is available from Skintique. Click below to check the latest price, availability, and any current offers.

👉 Check Latest Price
We may earn a commission if you purchase through this link at no extra cost to you.

Why people buy this

  • Popular choice in its category
  • Competitive pricing from trusted retailer
  • Fast online availability

Product details

Product Overview - SkinCeuticals Silymarin CF Vitamin C Antioxidant Serum | 30ml. SkinCeuticals Silymarin CF is an award-winning, oil-free vitamin C antioxidant serum specifically formulated for oily and blemish-prone skin. This breakthrough triple antioxidant formula combines 15% L-Ascorbic Acid (pure vitamin C), 0.5% Silymarin (milk thistle extract), 0.5% Ferulic Acid, and 0.5% Salicylic Acid to deliver advanced environmental protection whilst addressing both blemishes and visible signs of ageing.. The result of six years of clinical research and development, this professional-grade serum prevents oil oxidation that can lead to breakouts whilst reinforcing the skin's natural defence against free radical damage. Clinically proven to reduce oil oxidation by up to 76%, Silymarin CF is suitable for oily, combination, and blemish-prone skin types seeking comprehensive antioxidant protection without pore congestion.. Key Benefits at a Glance:. Immediate Benefits:. Advanced environmental protection against free radicals generated by UV radiation, pollution, and ozone. Lightweight, oil-free texture that absorbs quickly without leaving residue or causing additional oiliness. Matte finish that helps control shine throughout the day. Gentle exfoliation from salicylic acid to refine pores and prevent blemish formation. Visible skin smoothing and improved texture from first application. Long-Term Benefits:. With consistent daily use, Silymarin CF delivers clinically proven improvements in skin health and appearance. The powerful antioxidant complex works synergistically to reduce oil oxidation by up to 76%, helping prevent the cycle of inflammation and bacteria linked to blemish formation. Clinical studies demonstrate a 24% improvement in fine lines and wrinkles, alongside enhanced skin clarity, radiance, and tone evenness.. The formula's triple antioxidant system provides sustained protection against environmental aggressors whilst actively improving skin barrier function. Over 8-12 weeks, users experience refined pore appearance, balanced sebum production, and a visibly clearer, more luminous complexion with reduced signs of premature ageing.. How will it feel on my Skin?. Silymarin CF features a lightweight, fluid texture that spreads effortlessly across the skin. Upon application, the serum feels slightly aqueous with minimal tackiness that quickly dissipates as it absorbs. The oil-free formula leaves a mattifying finish without heaviness, making it ideal for layering under moisturiser and sunscreen. The skin feels smooth, refreshed, and balanced, with no greasy residue or pore-clogging sensation.. Who is it Suitable For?. Oily and combination skin types requiring antioxidant protection. Blemish-prone skin experiencing oil oxidation and breakouts. Mature oily skin seeking anti-ageing benefits without added congestion. Those with enlarged pores requiring refinement and texture improvement. Skin exposed to environmental aggressors (pollution, UV radiation, ozone). Adults seeking professional-grade vitamin C formulation for daily use. Why choose SkinCeuticals Silymarin CF?. Formulated under the prestigious Duke Antioxidant patent, Silymarin CF represents the pinnacle of vitamin C serum technology for oily and blemish-prone skin. Our experts recommend this clinically validated formula for its unique ability to address both environmental protection and blemish prevention simultaneously. Unlike conventional vitamin C serums, Silymarin CF specifically targets oil oxidation—the root cause of many breakouts—whilst delivering proven anti-ageing results backed by multiple clinical studies.